Pharma Playbook: Strategy Unlocked

Pharma Playbook

Introducing Pharma Playbook: Strategy Unlocked — where we break down the business, strategy, and science driving the pharma world forward. 

  1. Oct 4

    Pharma Playbook: Strategy Unlocked - Start With the Problem, Not the AI: Pharma's Missing Step

    AI pilots in pharma are stalling for a reason, and it is not the technology. The real problem is jumping straight to the shiny tool before defining the business problem, the workflow, and what success looks like after the pilot. Here, Nicole and Daanyaal break down why so many promising ideas end up in the "AI idea graveyard" and how to avoid wasting time on pilots that never scale. If your team is trying to move faster with AI, but governance, approvals, and duplicated efforts keep slowing everything down, this conversation gives you a clearer path forward. You will discover: Why "build it, buy it, or partner" is the first decision pharma teams should makeHow to start with a problem statement instead of forcing an AI mandateWhy even small wins like slide creation or localizing materials can unlock major efficiency gainsHow to keep pilots from dying after a successful test phaseWhy bringing governance, legal, and compliance in early changes everythingThe episode also unpacks a practical way to think about AI locally and globally, so teams avoid reinventing the wheel while still adapting tools to regional needs. The result is less duplication, less pilot fatigue, and more time spent on strategy and execution instead of admin work. If you work in pharma, marketing, operations, or innovation and you are trying to turn AI ideas into something real, this is the kind of conversation that helps you stop chasing the next shiny thing and start building something sustainable.

  2. Aug 18

    Pharma Playbook: Strategy Unlocked - Three Pharma Moves to Make in August Before Launch Delays End

    August is the hidden reset button for pharma, biotech, and healthcare teams. If your year has moved faster than expected or slower than planned, this episode gives you three practical ways to use the late-summer window before Q4 hits hard. Daanyaal and Nicole unpack why this moment creates unusual breathing room, how to turn slower summer conversations into valuable market intelligence, and why delays in approvals and access can actually become an advantage if you use them to pressure-test your launch plan.  You’ll discover: How to use casual conversations with HCPs, KOLs, and specialty pharmacy partners to surface insights you usually miss during peak seasonWhy launch readiness matters more when Health Canada, NLC, and access timelines shift unexpectedlyThe exact areas to map now, including patient support programs, brand planning, stakeholder engagement, medical affairs, and accessWhy August is the right time to plan for Q4, when trade, ad boards, final orders, and holiday timing all compress the calendarThe conversation also makes the bigger point clear: a delay is not always a setback. Sometimes it is the gift of extra time to catch blind spots, sharpen your communication plans, and make sure your next move is ready when the market finally opens up. Perfect for pharma, biotech, and healthcare professionals who need to regroup, get strategic, and finish the year strong without wasting the last stretch of summer.

  3. Aug 3

    Pharma Playbook - Strategy Unlocked: How AI-Driven Trade Tools Are Revolutionizing Pharma Supply Chain Efficiency

    Trade secrets doctors aren’t talking about — until now. What if there’s a way to unlock hidden insights from your pharma trade data faster, smarter, and with zero manual effort? In this episode of the Pharma Strategy Playbook, we reveal how AI-powered solutions like TradePipe and Tradeflow 360 are revolutionizing trade and distribution management in pharma — and it’s a game-changer for CEOs, trade managers, and supply chain leaders looking to stay ahead in a rapidly evolving landscape. Tune in as we discuss the critical role of trade and distribution at mid-year, highlighting the importance of analyzing sales trends, inventory levels, and market shifts before H2 kicks off. Daanyaal and Nicole introduce an innovative partnership with Cubitron that leverages AI to integrate multiple data sources, transforming fragmented, manual processes into a single governed intelligence hub. You’ll discover how these tools help identify market blips, predict shortages, and optimize supply — all with unprecedented speed and precision, reducing reliance on one-off reports and gut calls. We break down detailed insights on what’s happening in the pharma trade channel today: from how companies are preparing for drug shortages with predictive AI, to the strategic significance of upcoming trade boot camps and AI governance webinars. Plus, Daanyaal and Nicole share stories behind these innovations, explaining why every trade and supply chain leader must adapt now or risk falling behind in a competitive market. This episode is perfect for pharmaceutical execs, trade managers, and supply chain teams eager to harness data-driven insights for smarter decision-making. If you’re ready to upgrade from reactive troubleshooting to proactive strategic planning, you can’t afford to miss this.

About

Introducing Pharma Playbook: Strategy Unlocked — where we break down the business, strategy, and science driving the pharma world forward.